花旗发表研究报告指，ASMPT(00522.HK) 第一季业绩符合预期，主要是受惠于TCB(热压键合)大宗销售及半导体产品毛利率复苏。由于主流需求仍然疲软，第二季业绩展望略为令人失望。
管理层相信，其TCB可为封装HBM4提供特别效能，而HBM4可于下半年起量产。鉴于非先进封装(AP)业务复苏的不确定性上升，花旗下调集团预测，惟相信股价下调幅度有限，将目标价由75元降至65元，维持“买入”评级。(sl/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-30 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.